Brett Belongia, PhD

SVP CMC

Brett is the Senior Vice President of Technical Operations – CMC (Chemistry, Manufacturing, Control) at Boston Pharmaceuticals. Brett joined Boston Pharmaceuticals in August 2023 and is responsible for the strategic direction and execution of Boston Pharmaceutical’s development, manufacturing, and quality control for all programs including early-stage clinical development through commercialization.

Prior to joining Boston Pharmaceuticals, Brett was the Vice President of CMC Operations and the site head at Oncorus Inc, a company dedicated to developing the next generation of oncolytic viruses for the treatment of cancer. Under Brett’s leadership, Oncorus built significant internal process development, quality, and manufacturing expertise along with the construction of Oncorus’ internal GMP manufacturing facility to support Oncorus’ clinical drug product needs and minimize operational risk. Prior to Oncorus, Brett worked for over 18 years at Momenta Pharmaceuticals and EMD Millipore in multiple leadership roles in Process Development and Technical Operations.

Brett is the inventor on 13 patents and an author on multiple publications. Brett received his Ph.D. in Chemical Engineering from The University of Arizona after completing his BS in Chemical Engineering at The University of Wisconsin – Madison.